Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Earnings Release 2004

Dec 16, 2004

34595_rns_2004-12-16_5b48b710-2aea-438d-af56-ccde1df32f16.zip

Earnings Release

Open in viewer

Opens in your device viewer

8-K 1 bas8k.htm FORM 8K BIOANALYTICAL SYSTEMS, INC. Bioanalytical Systems, Inc. 8K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2004

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

BIOANALYTICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) — Indiana (State or other jurisdiction of incorporation or organization) 0-23357 (Commission File Number) 35-1345024 (I.R.S. Employer Identification No.)

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

2701 KENT AVENUE WEST LAFAYETTE, INDIANA (Address of principal executive offices) 47906-1382 (Zip Code)

Registrant's telephone number, including area code: (765) 463-4527

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default"

The information in this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 2.02. Results of Operations and Financial Condition.

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation"

On December 16, 2004, Bioanalytical Systems, Inc. (the “Company”) issued a press release announcing results for its fourth quarter and fiscal year ended September 30, 2004. The full text of the press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

Item 9.01. Financial Statements and Exhibits.

MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation"

(a) Not applicable.

MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation"

(b) Not applicable.

MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Default"

(c) Exhibits

99.1 Bioanalytical Systems, Inc. press release, issued December 16, 2004.

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Signature (Single)" FSL="Workstation"

Date: December 16, 2004 Bioanalytical Systems, Inc. By: /s/ Michael R. Cox Michael R. Cox VP-Finance, Chief Financial Officer and Treasurer

MARKER FORMAT-SHEET="Heading Center Bold" FSL="Workstation"

Exhibit Index

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

Exhibit No. 99.1 Description Bioanalytical Systems, Inc. press release, issued December 16, 2004.